Cargando…

LOSS OF THE TUMOR SUPPRESSOR, TP53, ENHANCES THE ANDROGEN RECEPTOR MEDIATED ONCOGENIC TRANSFORMATION AND TUMOR DEVELOPMENT IN THE MOUSE PROSTATE

Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological role of these dual genetic alterations in prostate tumorigenesis is largely unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yongfeng, Johnson, Daniel T., Yang, Julie S., Wu, Huiqing, You, Sungyong, Yoon, Junhee, Lee, Dong-Hong, Kim, Won Kyung, Aldahl, Joseph, Le, Vien, Hooker, Erika, Yu, Eun-Jeong, Geardts, Joseph, Cardiff, Robert D., Sun, Zijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752978/ https://www.ncbi.nlm.nih.gov/pubmed/31358900 http://dx.doi.org/10.1038/s41388-019-0901-8

Ejemplares similares

The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression
por: Olson, Adam, et al.
Publicado: (2019)

Deletion of the p16(INK4a) tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate
por: Lee, Dong-Hong, et al.
Publicado: (2019)

Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes
por: Kim, Won Kyung, et al.
Publicado: (2022)

ANDROGEN RECEPTOR WITH SHORT POLYGLUTAMINE TRACT PREFERABLY ENHANCES WNT/β-CATENIN MEDIATED PROSTATIC TUMORIGENESIS
por: He, Yongfeng, et al.
Publicado: (2020)

Loss of androgen signaling in mesenchymal sonic hedgehog responsive cells diminishes prostate development, growth, and regeneration
por: Le, Vien, et al.
Publicado: (2020)

Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis
por: Hiroto, Alex, et al.
Publicado: (2022)

A mutation screening of oncogenes, tumor suppressor gene TP53 and nuclear encoded mitochondrial complex I genes in oncocytic thyroid tumors
por: Evangelisti, Cecilia, et al.
Publicado: (2015)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
por: Szczepny, Anette, et al.
Publicado: (2018)

73565 Defining tp53 tumor suppressor functions in zebrafish embryonal rhabdomyosarcoma
por: Baxi, Kunal, et al.
Publicado: (2021)

Trans‐regulated Silencing and Reactivation of TP53 Tumor Suppressor Gene in Malignant Transformation and Its Reversion
por: Yang, Lichun, et al.
Publicado: (2000)

How TP53 (almost) became an oncogene
por: Weinberg, Robert A
Publicado: (2019)

ANDROGEN SIGNALING IS ESSENTIAL FOR DEVELOPMENT OF PROSTATE CANCER INITIATED FROM PROSATIC BASAL CELLS
por: He, Yongfeng, et al.
Publicado: (2018)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

Mutational hotspots in the TP53 gene and, possibly, other tumor suppressors evolve by positive selection
por: Glazko, Galina V, et al.
Publicado: (2006)

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
por: Jennis, Matthew, et al.
Publicado: (2016)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
por: Johnson, Daniel T., et al.
Publicado: (2016)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

Zebrafish imaging reveals TP53 mutation switching oncogene-induced senescence from suppressor to driver in primary tumorigenesis
por: Haraoka, Yukinari, et al.
Publicado: (2022)

Mutation Analysis of TP53 Tumor Suppressor Gene in Colorectal Cancer in Patients from Iran (Kerman Province)
por: Nejad, Azadeh Lohrasbi, et al.
Publicado: (2012)

Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region
por: Hedberg Oldfors, Carola, et al.
Publicado: (2015)

Loss of peptidase D binding restores the tumor suppressor functions of oncogenic p53 mutants
por: Yang, Lu, et al.
Publicado: (2021)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

miR-150-5p represses TP53 tumor suppressor gene to promote proliferation of colon adenocarcinoma
por: Liu, Fang, et al.
Publicado: (2019)

TP53 inhibitor PFTα increases the sensitivity of arsenic trioxide in TP53 wildtype tumor cells
por: Wang, Haiwei, et al.
Publicado: (2022)

Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation
por: Yeo, Shi Yun, et al.
Publicado: (2016)

Tumor suppressor p53 and metabolism
por: Liu, Juan, et al.
Publicado: (2018)

Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors
por: Krepischi, A. C. V., et al.
Publicado: (2016)

Damage‐inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter
por: Blackburn, James, et al.
Publicado: (2015)

The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor
por: Lee, Jane, et al.
Publicado: (2007)

Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
por: Lechner, J F, et al.
Publicado: (1997)

Genetic Basis for Carcinogenesis. Tumor Suppressor Genes and Oncogenes
por: Rabbitts, P.
Publicado: (1992)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

IGF-Binding Protein 2 – Oncogene or Tumor Suppressor?
por: Pickard, Adam, et al.
Publicado: (2015)

RhoB: Team Oncogene or Team Tumor Suppressor?
por: Ju, Julia A., et al.
Publicado: (2018)

Tumor Suppressors Having Oncogenic Functions: The Double Agents
por: Datta, Neerajana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ungb6269r2tkbgstrk6ljvv8a6